Data shown is for informational purposes only and does not constitute investment advice. TopFund is not SEBI-registered. Consult a SEBI-registered advisor before investing.
Hamps Bio IPO
Price Band
₹
Issue Size
₹6.22 Cr
Lot Size
2,000 shares
Min Investment
₹102,000
GMP
+₹60.0 (117.65%)
Issue Price
₹51.0
Subject to Sauda
₹91200
Paid only if allotted
Hamps Bio IPO AI Summary
- Hamps Bio IPO is listed on BSE SME in the Other Agricultural Products sector.
- Subscription window: 13 Dec–17 Dec 2024, listing on 20 Dec 2024.
- Current GMP is +₹60.0 (117.65%) — unofficial and can change daily.
TopFund is not SEBI-registered — this is educational analysis, not personalized investment advice.
Hamps Bio IPO — Third-Party Research Views
Reviews below reflect analyst calls made before this IPO closed on 17 Dec 2024 — not a current signal.
Recommendations are sourced from third-party research firms and are not TopFund's own investment advice.
Important Dates
Subscription Status
Subscription data unavailable
Hamps Bio IPO Grey Market Premium (GMP) Today
GMP
+₹60.0
GMP %
+117.65%
Est. Listing
₹111.0
Updated: 25 Jul 2026 14:02
About the Company
Incorporated in 2007, Hamps Bio Limited is engaged in the marketing and distribution of pharmaceutical products like tablets, syrups, capsules, injectables, oil, and nutritional supplements. The company distributes its products through a network of over 50 distributors and e-commerce platforms, including Amazon (US, Canada, EU), Flipkart, and Jio Mart. Their pharma products are sold in 8 states and union territories, while Freeze-dried and Frozen products reach 6 countries and 22 states and union territories. The company's business is divided into two segments: Pharmaceuticals: The company's pharmaceutical products are marketed under the "Hamps" brand. The range includes tablets, syrups, capsules, injectables, and powders. Freeze-dried and Frozen products: The FMCG division focuses on freeze-dried and frozen items under the "FzyEzy" brand. The company operates through both B2B and B2C models, offering products under its brand and through contract manufacturing. Freeze-dried and frozen products include Strawberry, Jamun, Mango, Beet Powder, Chikoo powder etc. The company offers over 180 products across both segments. As of October 31, 2024, The company had 78 employees. Competitive Strengths: Expert Leadership and Industry Experience Driving Strategic Business Growth Distribution Network with an Expansive E-Retailing Presence Wide and diversified range of products Diversified, global customer base with long-standing relationships Wide Geographical Presence Brand Identity
Company Financials (₹ Cr)
As of 2024-10-31
| Period Ended | 31 Oct 2024 | 31 Mar 2024 | 31 Mar 2023 | 31 Mar 2022 |
|---|---|---|---|---|
| Assets | 6.44 | 5.15 | 3.96 | 3.64 |
| Total Income | 4.36 | 6.50 | 5.58 | 5.34 |
| Profit After Tax | 0.34 | 0.50 | 0.36 | 0.12 |
| NET Worth | 3.71 | 3.37 | 1.36 | 1.01 |
| Reserves and Surplus | 0.57 | 1.41 | -0.14 | -0.49 |
| Total Borrowing | 1.38 | 1.05 | 1.74 | 2.04 |
Key Ratios
EPS
₹1.60
NAV
₹17.22
ROE
21.14%
ROCE
18.31%
RoNW
14.84%
P/B Value
2.96
P/E Ratio
31.94
Market Cap
₹22.22 Cr
PAT Margin
7.73%
Debt/Equity
0.31
Promoters
Herrik Shah, Shrenik Shah, Pallavi Shah, Mitali Shah, Herrik Shah (HUF) and Shrenik Shah (HUF)
Objects of the Issue
The Company proposes to utilise the Net Proceeds from the Issue towards the following objects: # Issue Objects Est Amt (₹ Cr.) 1 Purchase of plant & machinery for FMCG division; 3.59 2 Enhancing the visibility and awareness of our brand; 0.50 3 General corporate purposes 1.52
IPO Evaluation
Generated 23 Sep 2026Revenue Trend
Total income was ₹5.34 Cr in the year ending 31 Mar 2022, increasing to ₹5.58 Cr by 31 Mar 2023, then rising further to ₹6.50 Cr by 31 Mar 2024. However, for the most recent period ending 31 Oct 2024, total income decreased to ₹4.36 Cr, though this is a 9-month figure, not a full year, so isn't directly comparable.
Profit Trend
Profit after tax was ₹0.12 Cr for the year ending 31 Mar 2022, increasing to ₹0.36 Cr by 31 Mar 2023, and then to ₹0.50 Cr by 31 Mar 2024. In the latest period ending 31 Oct 2024, profit after tax decreased to ₹0.34 Cr, though this is a 9-month figure, not a full year, so isn't directly comparable.
Grey Market Premium, Explained
The grey market premium (GMP) refers to the unofficial trading of shares before they are listed on the stock exchange. A positive GMP indicates that investors expect the stock to list at a higher price than the issue price, while a negative GMP suggests the opposite.
Who This IPO Suits
Investors comfortable with short-term volatility and a long-term horizon typically weigh IPOs like this against their overall investment strategy and risk tolerance. It's important to consider the company's growth potential and market conditions.
Who May Want to Wait
Investors who are risk-averse or those who prefer stable, established companies may want to avoid IPOs like this, which can be more volatile and less predictable than established firms.
IPO Timeline, Explained
The IPO process includes several key dates: the opening date for subscription is December 13, 2024, the closing date is December 17, 2024, the allotment date is December 18, 2024, and the listing date is December 20, 2024.
Listing Gains — The Risk
Listing gains refer to the potential profit an investor can make when shares are listed on the stock exchange, often at a price higher than the issue price. However, these gains are not guaranteed and can vary based on market conditions and investor sentiment.
This evaluation is generated from Hamps Bio's own public IPO filing data for educational purposes and is not investment advice or a recommendation to apply, subscribe to, or avoid this issue — see Broker Recommendations below for named third-party research views (clearly attributed, not TopFund's own). TopFund is not a SEBI-registered investment adviser — see our Disclaimer.
Frequently Asked Questions
What is Hamps Bio IPO GMP today?
Hamps Bio IPO GMP today is +₹60.0 (117.65%). GMP is an unofficial grey-market indicator and can change daily.
When does Hamps Bio IPO open and close?
Hamps Bio IPO opens on 13 December 2024 and closes on 17 December 2024.
When does Hamps Bio IPO list on the stock exchange?
Hamps Bio IPO listed on 20 December 2024 at ₹111.0.
What is the lot size for Hamps Bio IPO?
The lot size for Hamps Bio IPO is 2000 shares, requiring a minimum investment of ₹102,000.
What is the issue price of Hamps Bio's IPO?
The issue price of Hamps Bio's IPO is ₹51.0.
What is the minimum investment required?
The minimum investment required is ₹102,000, which corresponds to a lot size of 2000 shares.
What are the key dates for the IPO?
The key dates are: Open Date - December 13, 2024; Close Date - December 17, 2024; Allotment Date - December 18, 2024; Listing Date - December 20, 2024.
What does GMP mean?
GMP stands for Grey Market Premium, which indicates the expected listing price of the shares compared to the issue price.
What is the expected listing gain percentage?
The expected listing gain percentage is 117.65%.
Issue Details
Investor Allocation
Registrar
Lead Managers / Book Running
IPO Timeline
Open
13 Dec 2024
Close
17 Dec 2024
Allotment
18 Dec 2024
Listing
20 Dec 2024
Similar IPOs in Other Agricultural Products
Plan Your IPO Investment
Related Articles
Community Sentiment
What are other investors planning for Hamps Bio?
No votes yet — be the first to share your view.
Sign in to voteDiscussion
User-generated content — not investment advice, and not verified or endorsed by TopFund.
No comments yet — start the discussion.